Study Details

8409-184-Group 11

Back To Current Studies

Healthy Non-Smoking Adults Needed

Study Number

8409-184-Group 11

Group

11

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Feb. 27 - Jul. 03, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Feb 20, 21, 24

Check-in: Feb 27

Check-out: Mar 6

Outpatient Visits: Mar 9, 13, 20, 27; Apr 10, 24; May 8, 22; June 5, 19; Jul 3

Study Number

8409-184-Group 11

Group

11

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Feb. 27 - Jul. 03, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Screening: Feb 20, 21, 24

Check-in: Feb 27

Check-out: Mar 6

Outpatient Visits: Mar 9, 13, 20, 27; Apr 10, 24; May 8, 22; June 5, 19; Jul 3

Calculate Your BMI!

Calculate Your BMI!